Host: |
Rabbit |
Applications: |
WB/ELISA |
Reactivity: |
Human |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.01% Thimerosal, 50% Glycerol, pH 7.3. |
Purification: |
Affinity purification |
Concentration: |
Lot specific |
Dilution Range: |
WB:1:500-1:2000ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements. |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
PARS2 |
Gene ID: |
25973 |
Uniprot ID: |
SYPM_HUMAN |
Immunogen Region: |
30-220 |
Specificity: |
Recombinant fusion protein containing a sequence corresponding to amino acids 30-220 of human PARS2 (NP_689481.2). |
Immunogen Sequence: |
HHCAPRRGRRLLLSRVFQPQ NLREDRVLSLQDKSDDLTCK SQRLMLQVGLIYPASPGCYH LLPYTVRAMEKLVRVIDQEM QAIGGQKVNMPSLSPAELWQ ATNRWDLMGKELLRLRDRHG KEYCLGPTHEEAITALIASQ KKLSYKQLPFLLYQVTRKFR DEPRPRFGLLRGREFYMKDM YTFDSSPEAAQ |
Function | Mitochondrial aminoacyl-tRNA synthetase that catalyzes the specific attachment of the proline amino acid (aa) to the homologous transfer RNA (tRNA), further participating in protein synthesis. The reaction occurs in a two steps: proline is first activated by ATP to form Pro-AMP and then transferred to the acceptor end of tRNA(Pro). |
Protein Name | Probable Proline--Trna Ligase - MitochondrialProlyl-Trna SynthetaseProrsProlyl-Trna Synthetase 2 - Mitochondrial |
Database Links | Reactome: R-HSA-379726 |
Cellular Localisation | Mitochondrion Matrix |
Alternative Antibody Names | Anti-Probable Proline--Trna Ligase - Mitochondrial antibodyAnti-Prolyl-Trna Synthetase antibodyAnti-Prors antibodyAnti-Prolyl-Trna Synthetase 2 - Mitochondrial antibodyAnti-PARS2 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance